Mcl-1 Blocks Radiation-induced Apoptosis and Inhibits Clonogenic Cell Death
Background: Anti-apoptotic Bcl-2 family proteins, such as Bcl-2 and Bcl-x, can modulate radio- and/or chemosensitivity of human malignancies. Since no information is available on the role Mcl-1 may play in the radioresponse of tumor cells, the relationship between Mcl-1 expression and response to io...
Saved in:
Published in: | Anticancer research Vol. 25; no. 4; pp. 2697 - 2703 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Attiki
International Institute of Anticancer Research
01-07-2005
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: Anti-apoptotic Bcl-2 family proteins, such as Bcl-2 and Bcl-x, can modulate radio- and/or chemosensitivity of
human malignancies. Since no information is available on the role Mcl-1 may play in the radioresponse of tumor cells, the
relationship between Mcl-1 expression and response to ionizing radiation (IR) was investigated using an antisense strategy.
Materials and Methods: Human melanoma cells were treated with Mcl-1 antisense oligonucleotides (ASOs) and IR. The effects
of antisense treatment alone or in combination with IR on proliferation, induction of apoptosis and clonogenic cell death
were evaluated. Results: ASO treatment in combination with IR reduced the mean cell numbers 9.5-fold compared to a 2.6-fold
reduction after ASO treatment alone and a 1.6-fold reduction after IR alone. The percentages of apoptosis measured (means±SD)
were 49%±3.0 in antisense/IR-treated cultures compared to 1.3%±0.5, 14.3%±0.5, 7.3%±1.1 and 10.3%±0.6 in ASO controls, in
antisense-treated, in IR-treated and in antisense control plus IR-treated cells, respectively. Colony formation assays demonstrated
a synergistic effect of Mcl-1 down-regulation with IR. Conclusion: Mcl-1 expression affects the radioresistance of human melanoma
cells. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0250-7005 1791-7530 |